The Waltham, Mass.-based company said that Cowen and Company will serve as its sales agent in the sale, but has not stated how many shares or other details of the offering yet.
The round will be an “at the market” offering through Cowen and Corindus said it may reimburse Cowen up to a maximum of $62,500 for expenses related to the offering, according to an SEC filing.
In May, Corindus saw shares fall after the robotic-surgery platform maker missed sales expectations on Wall Street with its first quarter 2018 earnings results.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.